BM30 is the first potent peptidomimetic inhibitor for N-terminal methyltransferase1/2 (NTMT1/2). BM30 has a half-maximal inhibitory concentration of 0.89 0.10 µM, is a competitive inhibitor to the peptide substrate and is noncompetitive to the cofactor
